These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1706799)

  • 1. Modulation of adrenoceptor-mediated cardiovascular effects by short-term in vivo infusion of isoproterenol in rats.
    Vleeming W; van Rooij HH; Wemer J; Porsius AJ
    J Cardiovasc Pharmacol; 1990 Oct; 16(4):584-93. PubMed ID: 1706799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of long-term pretreatment with isoproterenol on inotropic responsiveness to alpha-adrenoceptor stimulation: study in isolated perfused rat hearts.
    Silva CO; Monteiro-Filho WO; Duarte GP; Lahlou S
    J Pharm Pharmacol; 2001 Feb; 53(2):233-42. PubMed ID: 11273021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo cardiovascular responses to isoproterenol, dopamine and tyramine after prolonged infusion of isoproterenol.
    Hayes JS; Pollock GD; Fuller RW
    J Pharmacol Exp Ther; 1984 Dec; 231(3):633-9. PubMed ID: 6094797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective desensitization of cardiac beta adrenoceptors by prolonged in vivo infusion of catecholamines in rats.
    Chang HY; Klein RM; Kunos G
    J Pharmacol Exp Ther; 1982 Jun; 221(3):784-9. PubMed ID: 6283064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic intravenous infusions of dopexamine and isoprenaline to rats on D1-, beta 1- and beta 2-receptor-mediated responses.
    Martin SW; Broadley KJ
    Br J Pharmacol; 1994 Jun; 112(2):595-603. PubMed ID: 7915614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prolonged isoproterenol infusion on cardiac and vascular responses to adrenoceptor agonists.
    Hayes JS; Wyss VL; Schenck KS; Cohen ML
    J Pharmacol Exp Ther; 1986 Jun; 237(3):757-63. PubMed ID: 2423681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of beta adrenoceptor down-regulation on the cardiovascular responses to the stereoisomers of dobutamine.
    Hayes JS; Bowling N; Pollock GD
    J Pharmacol Exp Ther; 1985 Oct; 235(1):58-65. PubMed ID: 2995648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-adrenoceptor-mediated inhibition of alpha 1-adrenoceptor-mediated and field stimulation-induced contractile responses in the prostate of the guinea pig.
    Haynes JM; Hill SJ
    Br J Pharmacol; 1997 Nov; 122(6):1067-74. PubMed ID: 9401771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
    Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ
    Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
    Ebihara Y; Karmazyn M
    Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-hypertension effect of vanylidilol: a phenylaldehyde alpha/beta-adrenoceptor blocker with endothelium-dependent and K+ channels opening-associated vasorelaxant activities.
    Chiu CC; Wu JR; Lee CH; Liou SF; Dai ZK; Chen IJ; Yeh JL
    Pharmacology; 2004 Mar; 70(3):140-51. PubMed ID: 14752234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo.
    Ball DI; Brittain RT; Coleman RA; Denyer LH; Jack D; Johnson M; Lunts LH; Nials AT; Sheldrick KE; Skidmore IF
    Br J Pharmacol; 1991 Nov; 104(3):665-71. PubMed ID: 1686740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propranolol withdrawal supersensitivity in rat cardiovascular tissue, in vitro.
    Tenner TE
    Eur J Pharmacol; 1983 Aug; 92(1-2):91-7. PubMed ID: 6313393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of endothelial cells in relaxation and contraction responses of the aorta to isoproterenol in naive and streptozotocin-induced diabetic rats.
    Kamata K; Miyata N; Kasuya Y
    J Pharmacol Exp Ther; 1989 Jun; 249(3):890-4. PubMed ID: 2543815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of epinephrine, isoproterenol and IPS-339 on sympathetic transmission to the dog heart: evidence against the facilitatory role of presynaptic beta adrenoceptors.
    Yorikane R; Kanda A; Kimura T; Satoh S
    J Pharmacol Exp Ther; 1986 Jul; 238(1):334-40. PubMed ID: 3014122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced endogenous neurotransmitter overflow in the isolated perfused rat kidney after chronic epinephrine administration: lack of a prejunctional beta adrenoceptor influence.
    Schwartz DD; Eikenburg DC
    J Pharmacol Exp Ther; 1988 Jan; 244(1):11-8. PubMed ID: 2891841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
    Yeh JL; Liou SF; Liang JC; Huang YC; Chiang LC; Wu JR; Lin YT; Chen IJ
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):51-63. PubMed ID: 10630733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of beta 1- and beta 2-adrenoceptor stimulation on hemodynamics in the anesthetized rat.
    Abdelrahman A; Tabrizchi R; Pang CC
    J Cardiovasc Pharmacol; 1990 May; 15(5):720-8. PubMed ID: 1692931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of endothelium/nitric oxide in atypical beta-adrenoceptor-mediated relaxation in rat isolated aorta.
    Brawley L; Shaw AM; MacDonald A
    Eur J Pharmacol; 2000 Jun; 398(2):285-96. PubMed ID: 10854841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.